Other pathways or target molecules, such as Raf and PI3K/Akt [100], insulin-like growth factor-I receptor [101], ERK/FOXO3a [102], and miRNA-384/pleiotrophin [103], have been associated with the repression of CRC by luteolin. This evidence concerns the gene AKT1 and colorectal carcinoma.